The crucial role of LAT1 in cancer has also increased the interest in developing LAT1-inhibitors as potential anticancer agents, such as JPH203, which has already advanced into clinical trials in Japan to treat solid tumors [109]. The gene discussed is SLC7A5; the disease is cancer.